[Treatment of Xanthelesma palpebrarum with monochromatic green laser - about 20 patients]

To report the therapy of xanthelesma with a green laser as an alternative to surgery. A prospective study including 20 patients with xanthelasma of the eyelid were included in this study. The mean follow-up period was 5.8 months [range, 3 to 24 months]. All patients were satisfied regarding the laser therapy and the cosmetic result. Remarkably, the wounds were dry after laser therapy. No infections of the wounds occurred; wounds were epithelialized after 2 to 3 weeks by a normal-appearing epithelium. The area of argon laser treatment was less pigmented than the surrounding skin in one case. One case of relapse occurred in a patient with dyslipemia. Green laser therapy of xanthelasma seems to be a useful alternative to traditional surgery. It is easy to perform, well tolerated by the patients and shows excellent cosmetic results

[Cone-rod dystrophy: a case report]

Cone-rod dystrophy [CRD] is an inherited retinal dystrophy with initial loss of cone mediated functions followed by rod dystrophy. We report the case a young male affected by CRD. Case report: The case of a 27-year-old male patient is presented. He was hospitalized for decreased vision of both eyes and hemeralopia. The eye fundus examination showed bilateral lesions of retinitis pigmentosa in the supero temporal sector and macular cystoid oedema. Both photopic and scotopic full field ERG amplitudes were reduced, showing involvement of both photoreceptor systems. However, cone response was reduced more than that of rod response suggesting CRD diagnosis. His mother was diagnosed with age-related macular degeneration and his brother with CRD. The patient refused genetic analysis. Based on family history and clinical diagnosis, the disease was classified as cone-rod dystrophy. Discussion and Cone-rod dystrophy [CRD] is a particular form of retinitis pigmentosa [RP] which characteristically lead to early impairment of vision, usually from the first or second decade of life. CRD patients suffer from hemeralopia, loss of visual acuity and peripheral visual fields and show reduced ERG responses. In later life, vision may be reduced to a bare perception of light. Ophthalmoscopic abnormalities in CRD patients ranged from minor granular pigmentary changes in the posterior pole to widespread atrophy. Genetic analysis revealed various mutations in many genes may lead to CRD. There's no treatment available for this condition. Genetic advice is the most effective mean for preventing this inherited disease